Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH Level
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This study is designed in order to investigate the effect of cinacalcet in combination with
routine conventional medical management for treatment of secondary hyperparathyroidism (SHPT)
and Ca, P control. This study will compare the efficacy of a cinacalcet-based regimen with
unrestricted conventional care (vitamin D and phosphate binders) for achieving the stringent
National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI) targets for
dialysis patients.